Flynn Patrick John 4
4 · NRX Pharmaceuticals, Inc. · Filed Nov 29, 2022
Insider Transaction Report
Form 4
Flynn Patrick John
Director
Transactions
- Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+2,500$3,125→ 37,709 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+2,500$3,125→ 37,709 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+2,500$3,125→ 40,209 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.24/sh+2,500$3,100→ 40,209 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+1,750$2,188→ 1,750 total
Footnotes (4)
- [F1]Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
- [F2]Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
- [F3]Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
- [F4]Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.